347 filings
8-K
INM
InMed Pharmaceuticals Inc
18 Apr 24
Regulation FD Disclosure
1:30pm
8-K
INM
InMed Pharmaceuticals Inc
16 Apr 24
InMed Provides Update on INM-089 in the Treatment of Dry Age-Related Macular Degeneration
2:39pm
8-K
INM
InMed Pharmaceuticals Inc
5 Apr 24
Regulation FD Disclosure
11:26am
8-K
INM
InMed Pharmaceuticals Inc
20 Mar 24
InMed Granted 180-Day Extension to Achieve Nasdaq Minimum Bid Compliance
1:44pm
4
Andrew Hull
5 Mar 24
InMed Pharmaceuticals / ANDREW HULL ownership change
3:20pm
4
6f5akcp
5 Mar 24
InMed Pharmaceuticals / ERIC C HSU ownership change
3:20pm
4
4y9tvf
5 Mar 24
InMed Pharmaceuticals / ALEXANDRA DIANE JANET MANCINI ownership change
3:20pm
3
xxer4ayswahgei301o6
27 Feb 24
InMed Pharmaceuticals / Netta Jagpal ownership change
3:27pm
4
okmas rnmgjt52
22 Feb 24
InMed Pharmaceuticals / ANDREW HULL ownership change
1:38pm
4
fbl6oy91i9jiu
21 Feb 24
InMed Pharmaceuticals / ERIC A ADAMS ownership change
2:58pm
SC 13G/A
g0y0iqts gp
14 Feb 24
InMed Pharmaceuticals / ARMISTICE CAPITAL ownership change
2:28pm
8-K
2nqye30wxva h2wn
13 Feb 24
InMed Reports Second Fiscal Quarter 2024 Financial Results and Provides Business Update
7:34pm
8-K
tqiulto5mhdwa1mh
9 Feb 24
InMed Pharmaceuticals Strengthens Executive Leadership Team with Appointment of Ms. Netta Jagpal as Chief Financial Officer
12:34pm
8-K
5xezgxtp8wur6x9z gl
19 Jan 24
Regulation FD Disclosure
2:33pm
8-K
y81x9oc3
16 Jan 24
InMed Pharmaceuticals Provides Business Update and Milestones for 2024
2:12pm
SC 13G
1el6kplyfa2
4 Jan 24
InMed Pharmaceuticals / SABBY MANAGEMENT ownership change
12:00am
4
4hu5rsz8 vt26
26 Dec 23
InMed Pharmaceuticals / Shane Aaron Johnson ownership change
1:09pm
4
9cxn43 h3p5xuu5
26 Dec 23
InMed Pharmaceuticals / Nicole Lemerond ownership change
1:09pm
4
m4nmeh4xfr
26 Dec 23
InMed Pharmaceuticals / MICHAEL WOUDENBERG ownership change
1:09pm